Latest news and blogs

One of our key projects to transform and improve cancer care is up for a prestigious HSJ award. Our RAPID (Rapid Access to Prostate Imaging …

The Pan-London Selection Committee has awarded six research fellowships for 2018/19, focusing on early diagnosis, living with and beyond cancer and big data. The 12 …

RM Partners is working with the NW London Cancer Primary Care Board to pilot an electronic safety netting tool in GP practices across Brent, Harrow …

RM Partners is working in partnership with the Merton GP Federation and Merton CCG to offer new evening and weekend cervical cancer screening clinics at convenient …

RM Partners is supporting a small pilot project in Sutton to help GPs learn to better identify suspicious skin lesions and increase appropriate referrals. Working …

RM Partners held the first RAPID prostate pathway network meeting to share data, look at the similarities and differences of the three pilot pathways, and …

RM Partners has just launched a pilot in Sutton that uses an award winning AI decision support tool, C the Signs, to help GPs identify …

The second cancer biosimilar, trastuzumab, has been approved to treat patients with HER2-positive early breast cancer, metastatic breast cancer, and metastatic gastric cancer. Biosimilar trastuzumab …

Clinicians from the three hospitals piloting the RM Partners RAPID prostate pathway attended an education day at Epsom Hospital that offered training in the use …

We are offering exciting opportunities for medical and non-medical research fellows to undertake a research project. This has London-based support from Biomedical Research Centres, RM …